Liquid suspension concentrate formulations containing saflufenacil and glyphosate

US9545104B2 · kind B2 · utility

Assignee

• BASF SE

Inventors

• Michael Krapp · Nattheim, DE
• Wolfgang Gregori · Ludwigshafen, DE
• Sven Adam · Kandel, DE
• Klaus Kolb · Schifferstadt, DE
• Jürgen Jakob · Gronau, DE
• Bernd Sievernich · Böhl-Iggelheim, DE
• Jörg Steuerwald · Haßloch, DE
• Steven Bowe · Темневкий пруд, US
• Joseph Zawierucha · Cary, US
• Rex A. Liebl · Raleigh, US

Key dates

• Filing date: Dec 8, 2010
• Grant date: Jan 17, 2017
• Expiry date: Feb 11, 2032

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A01N57/20
• WIPO field: Basic materials chemistry
• WIPO sector: Chemistry

Abstract

The present invention relates to liquid suspension concentrate formulations for plant protection comprising: 2-chloro-5-[3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)-1-(2H)pyrimidinyl]-4-fluoro-N-[[methyl(1-methylethy)amino]sulfonyl]benzamide in the form of the anhydrate; N-(phosphonomethyl)glycine in the form of its free acid, in the form of the ammonium salt or a substituted ammonium salt or a mixture thereof; at least one diluent selected from: hydrocarbon solvents having a boiling point of at least 100° C.; and —C1-C8-alkyl esters of C8-C26-fatty acids, mono- and di-C1-C4-alkyl amides of C8-C26-fatty acids; optionally at least one diluent that differs from diluents c) and that is selected from organic solvents having at least one oxygen atom; at least one non-ionic surfactant comprising a polyalkoxylate moiety; and at least one anionic surfactant containing a sulfonate group or a sulfate group.